What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Cytovale

Providing rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.

03/16/2026

👀 SEP-1 is evolving — and so is sepsis strategy.

As performance ties more directly to reimbursement, hospitals are taking a closer look at how early ED decisions affect operations, capacity, and financial risk.

Join us for a -hosted webinar on early ED decision-making and sepsis risk assessment.

🗓 March 19 | 12–1 PM CT
🎙 Expert panel featuring leaders from , , and

📍Register now: https://na2.hubs.ly/H0477SP0

03/12/2026

Kidney dysfunction is one of the earliest indicators of severe sepsis, but it’s not always visible on arrival.

This World Kidney Day, we’re spotlighting the importance of proactive risk assessment in the ED. When clinicians can identify early signs of immune dysregulation, they’re better equipped to intervene before organ dysfunction escalates.

03/09/2026

During Patient Safety Awareness Week, we recognize the clinical teams working to protect patients, especially in fast-paced, high-pressure environments like the ED.

When time is short and uncertainty is high, earlier insight at triage can help guide the safest next step. Whether it’s sepsis or another serious condition, timely risk assessment supports faster, more confident decisions when stakes are highest – and safer care.

03/06/2026

SEP-1 performance is no longer just a quality metric. It’s increasingly tied to financial exposure, operational strain, and downstream capacity decisions.

As Value-Based Purchasing raises the stakes, many hospitals are re-examining how early sepsis decisions in the ED shape outcomes well beyond compliance.

Join us for a Becker’s Healthcare–hosted webinar exploring:

Where compliance-first sepsis strategies fall short
How early ED decision-making affects throughput and capacity
Why host-response insights are becoming part of modern sepsis strategy

🗓 Thursday, March 19
🕛 12:00–1:00 PM CT
🎙Speakers from Franciscan Missionaries of Our Lady Health System, Lehigh Valley Health Network & University Hospitals

🔗 Register now: https://na2.hubs.ly/H0475-70

01/08/2026

“We had no tools in the toolbox. IntelliSep changed everything.”
That’s what St. Dominic’s team said about their sepsis workflow, before and after implementing IntelliSep.

See the impact after nearly a year of using IntelliSep, including:
→ Reduced blood culture utilization 19%
→ Reduced sepsis mortality by 43%
→ Reduced length of stay by 0.9 days

🎥 Watch now: https://na2.hubs.ly/H02Wjsj0

01/07/2026

Sepsis is one of the most costly, complex, and deadly challenges in emergency medicine.

But it doesn’t have to be a mystery.
That’s where IntelliSep comes in.

Powered by machine learning
Pathogen agnostic with the ability to SEE immune activation
Enabling hosptials to reduce sepsis-related mortality, LOS, and unnecessary treatment

MedTech Dive digs into into Cytovale’s flagship diagnostic, and how it's helping clinicians risk-stratify suspected sepsis in minutes, right at triage.

Read the full feature → https://na2.hubs.ly/H02WdXS0

12/30/2025

Looking ahead to 2026, one thing is clear: the fight against sepsis isn’t slowing down, and neither are we.

As cases rise globally, the need for faster, data-driven decisions in the emergency department has never been more critical. In 2025, Cytovale helped accelerate sepsis care across the country. In 2026, we’re doubling down on precision, performance, and partnerships.

We’re advancing early diagnostics to help ED teams act faster and more confidently. Because when every minute matters, innovation isn’t optional, it’s urgent.

Follow along as we build what’s next. https://na2.hubs.ly/H02Dpn_0

12/29/2025

As the year draws to a close, we’re grateful for the healthcare leaders, clinicians, and teams who work tirelessly to keep sepsis in check. Thank you for your commitment to advancing care, accelerating diagnosis, and improving outcomes for patients across the country.

Wishing you a season of health, joy, and rest.
— The Cytovale Team

12/23/2025

How does your emergency department measure ROI?
For many systems, sepsis is one of the costliest conditions they manage, with average treatment costs exceeding $32,000 per case. The faster sepsis is identified and ruled in or out, the faster teams can optimize resource use:

✅ Reduced diagnostic waste
✅ Better antibiotic stewardship
✅ Shorter LOS
✅ Smoother transfers
✅ Stronger throughput

We’re committed to providing decision support tools that not only improve sepsis care but reshape how emergency departments allocate resources. The result? Better outcomes for patients and operations alike.

Learn more: https://na2.hubs.ly/H02DqQr0

12/22/2025

Sepsis remained a global threat in 2025, with an estimated 1.7 million adults in the U.S. affected each year and nearly 350,000 deaths. Worldwide, it continues to account for 1 in 5 deaths, many of them preventable with earlier, data-informed intervention.

At Cytovale, our mission is clear: deliver faster answers in the moments that matter most. In 2025, we made meaningful strides—from expanding access to real-time immune response testing to helping clinicians improve decision-making under pressure.

We’re proud of our progress. But we know the urgency hasn’t changed.

👉 Here’s to smarter systems, swifter triage, and stronger outcomes in 2026.

12/18/2025

On Vizient’s podcast, Ajay and Dr. Chris Thomas, Vice President and Chief Quality Officer at Franciscan Missionaries of Our Lady Health System, reflect on how rapid sepsis detection isn’t just about innovation — it’s about saving lives, faster.

Tune in to hear how frontline teams are using new tools like IntelliSep, to see the biology of sepsis, and intervene earlier than ever. https://na2.hubs.ly/H02Jj-c0

12/17/2025

As we close out the year, we’re proud of the progress Cytovale has made toward our goal: delivering earlier, objective sepsis risk insights that help clinicians act faster and help more patients survive.

2025 highlights:

➡️ Published real-world evidence from a 12,000+ patient study
➡️ 500+ physicians now using IntelliSep in practice
➡️ 60,000+ patients tested with IntelliSep
➡️ Connected with hundreds of hospital executives, physician leaders, and patients at conferences and events
➡️ Built strong momentum with partners, supporting system expansion and broader access

What’s next for Cytovale:
➡️ Generating new evidence to deepen clinical impact
➡️ Strengthening existing partnerships
➡️ Building new partnerships to expand access nationwide

To the frontline clinicians caring for patients every day, our hospital partners who collaborate with us, and the Cytovale team pushing this mission forward, thank you. Your commitment is what makes this progress possible.

Address

2 Tower Place
South San Francisco, CA
94080

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+14154172188

Website

http://www.cytovale.com/

Alerts

Be the first to know and let us send you an email when Cytovale posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cytovale:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in South San Francisco?